V
BMY icon

VeraBank’s Bristol-Myers Squibb BMY Stock Holding History

VeraBank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$285K Sell
4,694
-47
-1% -$2.74K 0.05% 151
2025
Q4 		$256K Sell
4,741
-33
-0.7% -$1.59K 0.05% 163
2025
Q3 		$215K Sell
4,774
-1,834
-28% -$85.7K 0.04% 178
2025
Q2 		$306K Buy
6,608
+271
+4% +$13.3K 0.06% 151
2025
Q1 		$386K Buy
6,337
+29
+0.5% +$1.69K 0.11% 109
2024
Q4 		$357K Sell
6,308
-191
-3% -$10.7K 0.1% 111
2024
Q3 		$336K Sell
6,499
-100
-2% -$4.69K 0.1% 116
2024
Q2 		$274K Hold
6,599
– – 0.09% 124
2024
Q1 		$358K Sell
6,599
-47
-0.7% -$2.39K 0.11% 111
2023
Q4 		$341K Sell
6,646
-2
-0% -$105 0.11% 110
2023
Q3 		$386K Hold
6,648
– – 0.15% 104
2023
Q2 		$425K Hold
6,648
– – 0.16% 97
2023
Q1 		$461K Hold
6,648
– – 0.21% 88
2022
Q4 		$478K Sell
6,648
-2
-0% -$151 0.24% 79
2022
Q3 		$472K Sell
6,650
-861
-11% -$62.5K 0.3% 73
2022
Q2 		$578K Buy
7,511
+40
+0.5% +$3.05K 0.34% 69
2022
Q1 		$546K Hold
7,471
– – 0.28% 79
2021
Q4 		$466K Hold
7,471
– – 0.24% 87
2021
Q3 		$442K Hold
7,471
– – 0.25% 85
2021
Q2 		$499K Hold
7,471
– – 0.3% 74
2021
Q1 		$472K Buy
7,471
+100
+1% +$6.22K 0.31% 74
2020
Q4 		$457K Hold
7,371
– – 0.32% 70
2020
Q3 		$444K Hold
7,371
– – 0.34% 68
2020
Q2 		$433K Sell
7,371
-533
-7% -$31.9K 0.35% 68
2020
Q1 		$440K Hold
7,904
– – 0.43% 62
2019
Q4 		$508K Buy
7,904
+779
+11% +$44.6K 0.41% 63
2019
Q3 		$362K Buy
7,125
+361
+5% +$17K 0.33% 67
2019
Q2 		$307K Hold
6,764
– – 0.29% 74
2019
Q1 		$323K Hold
6,764
– – 0.31% 73
2018
Q4 		$352K Buy
+6,764
New +$363K 0.38% 63

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VeraBank's BMY Position: Q1 2026 in Review

VeraBank reduced its Bristol-Myers Squibb (BMY) stake by 0.99% in Q1 2026, selling an estimated $2.74K and leaving 4,694 shares worth $285K. The position accounts for 0.05% of the portfolio, ranked #151.

VeraBank first reported a position in BMY in Q4 2018 and has held it in 30 quarters since. The position peaked at $578K in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • VeraBank held 4,694 shares of Bristol-Myers Squibb worth $285K as of Q1 2026.
  • VeraBank sold 47 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.74K.
  • Bristol-Myers Squibb made up 0.05% of VeraBank's portfolio in Q1 2026, its #151 holding.
  • VeraBank first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 30 quarters since.
  • VeraBank's Bristol-Myers Squibb position peaked at $578K in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on VeraBank's 13F filing for Q1 2026, filed 12 May 2026.